HARVARD BIOSCIENCE INC — Director's Dealing 2019

Sep 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2019-09-11

Reporting Person: LOY BERTRAND (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-11	Common Stock	P	15590	$3.01	Acquired	138674	Direct
2019-09-12	Common Stock	P	11297	$3.07	Acquired	149971	Direct
2019-09-13	Common Stock	P	7372	$3.11	Acquired	157343	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	68466	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $2.93 to $3.10, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Includes (a) a deferred stock award of 6,600 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; (b) a deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; (c) a deferred stock award of 7,000 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; and (d) 89,974 shares of common stock held by the Reporting Person

F3: This transaction was executed in multiple trades at prices ranging from $2.97 to $3.14, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: Includes the awards referenced in clauses (a) through (c) of footnote (2) above, plus 101,271 shares of common stock held by the Reporting Person.

F5: This transaction was executed in multiple trades at prices ranging from $3.04 to $3.14, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: Includes the awards referenced in clauses (a) through (c) of footnote (2) above, plus 108,643 shares of common stock held by the Reporting Person.